In contrast, the combination of pyridostatin with NU‐7441 or paclitaxel showed an anti‐tumoral effect superior to each single drug against BRCA2−/− HCT116 tumours, although they did not prevent tumour growth in the long term (Fig 6A–C; Table 4). Here, BRCA2 is linked to neoplasm.